SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes

NCT04816084 | Completed

• 1 other identifier: 2020-004-SERUR
• Study Type: interventional
• Target: 389
• Locations: 1 country
• Sites: 1

Brief Summary

This study was designed to determine, in a screening situation within the framework of university preventive medicine, the prevalence of positive anti-SARS-Cov 2 serology among the staff of the University of Reims Champagne-Ardenne. The serological tests chosen will allow systematic detection of anti-SARS-CoV-2 IgM and anti-SARS-Cov-2 IgG to assess the moment of potential contamination prior to resumption of occupational activity.

Conditions

Covid19

Keywords

COVID-19; SARS-CoV2 antibodies

Outcome Measures

Primary Outcomes (1)

• Prevalence of IgG and IgM anti-SARS CoV2 antibodies

  Anti-SARS-Cov2 seroprevalence measured in blood sample collected at Day 0.

  Inclusion time was ½ day, time for blood sampling

Study Arms (1)

Population

EXPERIMENTAL

Voluntary people over 18 from the staff of the University of Reims Champagne Ardenne

Diagnostic Test: Anti-SARS-CoV2 Serology

Interventions

Anti-SARS-CoV2 Serology DIAGNOSTIC_TEST

Diagnostic Test: Anti-SARS-CoV2 Serology A blood sample is collected by venipuncture at Day 0. The anti-SARS-CoV2 serological status is measured by with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays (EUROBIO®) Other: Questionnaire Data concerning personal exposure factors are collected in a questionnaire: * Socio-demographic factors: sex, age, * known risk-factor for Covid-19 * Professional factors: Employment (type, work time, location), protective measures put in place to reduce the risk of contamination * Non-professional factors: Contact with infected individuals, carrying of protective equipment and compliance with barrier measures, transport and accomodation modalities during holidays

Also known as: other : questionnaire

Population

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Major volunteers from the Staff of the University of Reims Champagne-Ardenne (\>18 years old)

You may not qualify if:

• persons who do not desire to participate

Sponsors & Collaborators

• Université de Reims Champagne-Ardenne: lead

Study Sites (1)

Université de Reims Champagne-Ardenne

Reims, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Delphine GIUSTI, MCU-PH

  Université de Reims CHampahne-Ardenne - CHU de Reims

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 19, 2021
• First Posted: March 25, 2021
• Study Start: November 5, 2020
• Primary Completion: December 1, 2020
• Study Completion: March 15, 2021
• Last Updated: March 25, 2021

Record last verified: 2021-03

Locations

FR (1)